VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1000521
Sex: M
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210117; Test Name: Pain scale; Result Unstructured Data: Test Result:5/10

Allergies:

Symptoms: swollen lymph node; Pain started on Sunday, 17Jan2021. 5/10 pain scale on Sunday.; felt a tickle behind his left ear; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (reported age was 62 without unit) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date were not reported), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. During the injection on 16Jan2021, the patient felt a tickle behind his left ear. Pain started on Sunday, 17Jan2021. 5/10 pain scale on Sunday. He stated that "it hurts more after 8 hours of work, in the morning it is good." The patient believes it is a "swollen lymph node." Outcome of the events was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1000522
Sex: M
Age:
State: AZ

Vax Date: 01/16/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain in right groin; difficulty walking; arm soreness; redness on the toe of his left foot; This is a spontaneous report from a contactable consumer (patient himself). An 86-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL1284, expiration date was unknown), via an unspecified route of administration on the left arm on 16Jan2021 at a single dose for COVID-19 immunization; it was offered to him and he was in the Phase 1B category. Relevant medical history included ongoing type 2 diabetes mellitus, which was diagnosed 10-15 years prior reporting, had a watchman procedure on an unspecified date, and had used a cane to walk before. Concomitant medication included clopidogrel as a blood thinner from 15Jan2021 and ongoing, which he would take for 6 months. The patient previously took apixaban (ELIQUIS). It was reported that he had a watchman procedure and they took him off of apixaban and started him on clopidogrel. In 6 months, he would not have to take any blood thinners and would make an appointment with his physician. On 18Jan2021, at noon, the patient was experiencing pain in his right groin. As the day progressed it got worse. By night (18Jan2021), he was in extreme pain and had difficulty walking. He had to use a walker to walk. It had let up, but he still had pain in the groin of his right leg. The patient was asking if there were certain doctors that could assist him with this problem. He was no longer using a walker. He was using a cane instead. He used a cane to walk with before this, but not for this reason. He never had any real serious aching. He had a little soreness in his arm on an unspecified date in Jan2021, but nothing out of the ordinary. He didn't know his arm was sore until he rubbed it. He though it might have been on Sunday when he noticed it. He was not sure. Prior to this, he had redness on the toe of his left foot on an unspecified date in Jan2021. He was prescribed an antibiotic that he was still taking. He was unable to provide the name of the antibiotic. Therapeutic measures were taken as a result of "difficulty walking and redness on the toe of his left foot. The patient had no investigation assessment. The patient was recovering from the event "pain in right groin," he was not recovered from the event "difficulty walking," while the outcome of the events "arm soreness and redness on the toe of his left foot" was unknown.

Other Meds: CLOPIDOGREL

Current Illness: Type 2 diabetes mellitus (Diagnosed 10-15 years ago)

ID: 1000523
Sex: F
Age:
State: LA

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210120; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210120; Test Name: PCR; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Headache; vascular rash on toes; This is a spontaneous report from a contactable consumer (patient). A 63 year-old female patient received first dose of BNT162B2 (lot number: 3246), via an unspecified route of administration on 16Jan2021 14:30 at single dose in the left arm for COVID-19 immunization. Medical history included chronic lymphocytic leukaemia from an unknown date. The patient has no known allergies. Concomitant medication included metformin extended release. On 16Jan2021, the patient experienced headache and vascular rash on toes. The events resulted in doctor or other healthcare professional office/clinic visit. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient received any treatment for the events. The patient underwent lab tests and procedures which included PCR and nasal swab: both unknown results on 20Jan2021. The outcome of the events was not recovered.

Other Meds: METFORMIN

Current Illness:

ID: 1000524
Sex: F
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tends to have low blood pressure; Dizziness; she lies down and then gets up she is dizzy; tired; she might have almost fainted as the room was spinning; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL1284, expiration date 0Apr2021), via an unspecified route of administration in the left arm on 18Jan2021 at 09:30 (at the age of 72-years-old) as a single dose for COVID-19 vaccination. Medical history included Reflux esophagitis, COPD and a root canal on 14Jan2021. Historical vaccinations included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 28Dec2020. Past drug history includes sore arm after COVID-19 vaccination on 28Dec2020. It was unknown if the patient has any allergies to medications, food, or other products. The patient's concomitant medications included oral famotidine (FAMOTIDINE) 20mg twice daily for reflux, (tiotropium bromide) SPIRIVA 2.5mcg, two puffs once daily by mouth for COPD, latanaprost (LATANAPROST)125mcg; one drop each eye at night for Glaucoma, (TIMOLOL) 5% one drop twice daily to each eye and (LORATADINE) 10mg; take once daily by mouth as needed for allergy. The patient did not receive any other vaccine within four (4) weeks prior to the vaccine. The vaccine was administered to the patient at the hospital. On 19Jan2021 the patient experienced dizziness and feeling tired. The patient further described that she had the vaccine on Monday and since yesterday, when she woke up, she has a lot of dizziness; and again this morning when she woke up. Also, when she lies down and then gets up she is dizzy. Mentions she didn't see dizziness on the list of side effects. She knows that is a side effect of COVID. She is asking is dizziness is a side effect of the vaccine wants to know if she should call her doctor. She continued and mentioned that she noticed when she was waking up on 19Jan2021 she was so dizzy that she couldn't get out of bed. Adds she thinks she might have almost fainted as the room was spinning. Mentions she tends to have low blood pressure but this is not typical. As far as side effects from the vaccine she mentions she is tired. The tiredness started after the second dose and has continued through today but not as bad. The clinical outcome of dizziness was reported as not recovered, the outcome of fatigue was recovering and the outcome of almost fainted and low blood pressure was unknown.

Other Meds: FAMOTIDINE; SPIRIVA; LATANOPROST; TIMOLOL; LORATADINE

Current Illness:

ID: 1000526
Sex: F
Age:
State: NC

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:normally it runs low in the 90s; Test Date: 20210115; Test Name: blood pressure; Result Unstructured Data: Test Result:110/60

Allergies:

Symptoms: Right eyelid feels heavy; She slept all day Sunday; Extreme fatigue; Flushed feeling; lightheaded/dizzy; lightheaded/dizzy like she was going to pass out; Had a heavy feeling in her throat and chest/Had a heavy feeling on her face- had removed her mask but it still felt like she still had it on; Had a heavy feeling in her chest; Tingling sensation on her lips; Tingling sensation on the right side of her face, and cheek; Severe burning in her right ear; Sore throat on the right side; When she was speaking it sounded like she had a thick tongue; Tongue feels swollen; Pain at the base of her skull on the right side; Pain on the right side of her forehead; Pinpoint pain that went down the right side of her spine; Metallic taste in her mouth; felt off; Pain at the injection site; It was so bad that it would wake her up if she rolled over; This is a spontaneous report from a contactable Nurse reporting for herself. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL3248), via an unspecified route of administration on 15Jan2021 at single dose (Once by injection in the right arm) for COVID-19 immunisation. The patient medical history was not reported. Historical vaccine included Hepatitis B vaccine. There were no concomitant medications. On 15Jan2021, after 15 minutes of monitoring she was fine. 5 minutes later or so (after 20 minutes), she had a flushed feeling and was lightheaded/dizzy like she was going to pass out. She returned to her office. She had someone check her blood pressure which was fine. It was 110/60. Normally it runs low in the 90s. Again, she thought she looked flushed. It was reported she had a heavy feeling in her throat and chest and on her face. She had removed her mask but it still felt like she still had it on. She had brought Benadryl with her, as she has had a reaction to the Hepatitis B vaccine before. She took the Benadryl since she felt off. She thinks this first part of what she experienced triggered everything else. By the time she got home, she had a tingling sensation on the right side of her face, on her lips and cheek. She had severe burning in her right ear. She also had a sore throat on the right side. Heaviness in her throat and chest- resolved late Saturday to early Sunday (Jan2021). Her husband noticed on Friday evening (15Jan2021) when she was speaking it sounded like she had a thick tongue. Saturday morning it was more normal. Her tongue does feels swollen. She also developed pain at the base of her skull on the right side. This started about 2 hours after the vaccine. She had pain on the right side of her forehead. She had pinpoint pain that went down the right side of her spine. She also developed a metallic taste in her mouth. She had pain at the injection site. It was so bad that it would wake her up if she rolled over. On 17Jan2021, she slept all day Sunday and also had extreme fatigue. On 18Jan2021, her right eyelid feels heavy on 18Jan2021. She does not think any of these are serious, but stated they are concerning. Vaccination card does not have the NDC or expiration date on it. Patient asked is getting the second dose of the injection recommend. She is leaning towards no but wanted to see what was recommended. She has reached out to her primary care about this. Outcome of the events flushed feeling, lightheaded/dizzy, lightheaded dizzy, like she was going to pass out was recovered on 15Jan2021. Outcome of the events when she was speaking it sounded like she had a thick tongue was recovered on 16Jan2021; Outcome of the events pain at the base of her skull on the right side, pain on the right side of her forehead, pinpoint pain that went down the right side of her spine, extreme fatigue, pain at the injection site was recovered on 17Jan2021; Outcome of the events Had a heavy feeling in her throat and chest/Had a heavy feeling on her face- had removed her mask but it still felt like she still had it on, and Had a heavy feeling in her chest was recovered on Jan2021. Outcome of the events severe burning in her right ear, sore throat on the ride side, tingling sensation on her lips, tingling sensation on the right side of her face and cheek was recovering. Outcome of the events tongue feels swollen, metallic taste in her mouth, right eyelid feels heavy was not recovered. Outcome of the events it was so bad that it would wake her up if she rolled over, she slept all day Sunday, and felt off was unknown. The reporter considered the events as non-serious. Causality assessment for events for felt off, she slept all day Sunday, It was so bad that it would wake her up if she rolled over was not reported. Causality assessment for all other events was reported as related.

Other Meds:

Current Illness:

ID: 1000527
Sex: F
Age:
State: MN

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I was so faint/nearly passed out; so hot; very chilled for about 15 or 20 minutes; feeling sort "off"; weak; fatigued/very drained/exhausted; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK4176), via an unspecified route of administration on 19Jan2021 at 08:15 AM at single dose in right arm for COVID-19 immunisation. Patient age at time of vaccination was years 30 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient has no known allergies. The patient had no relevant medical history and received no concomitant medications. The patient reported the following: 'About 5 minutes after receiving the vaccine I was so faint I nearly passed out and was so hot I was given an ice pack to try and cool me down. It took about 45 minutes for me to be able walk across one room. I then was very chilled for about 15 or 20 minutes, and very drained. The rest of the day I was back and forth between feeling sort "off" and feeling like I was weak, exhausted, and fatigued'. Adverse events onset date was reported as 19Jan2021 at 08:15 AM. No treatment was received for the events other than ice pack for feeling hot. The patient was recovering from the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1000528
Sex: M
Age:
State: GA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm was a little blue after receiving injection; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EK9231, expiration date unknown), via an unspecified route of administration in the left arm on 12Jan2021 (at the age of 66-years-old) as a single dose for COVID-19 vaccination. Medical history included "cholesterol." The patient's concomitant medications included rosuvastatin calcium (CRESTOR) 10 mg daily. It was unknown if the patient has any allergies to medications, food, or other products. It was unknown if the patient had received any other vaccines within four (4) weeks prior to the vaccine. On 13Jan2021 the patient added that his arm was "a little blue" after receiving the injection. Treatment information, if any, was not provided. The clinical outcome of vaccination site discoloration was reported as recovered on 13Jan2021.

Other Meds: CRESTOR

Current Illness:

ID: 1000529
Sex: F
Age:
State: WA

Vax Date: 01/04/2021
Onset Date: 01/10/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash broke out all over my neck; This is a spontaneous report from a contactable physician (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231; expiration date not provided), via an unspecified route of administration in the left arm on 04Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included Mild anxiety, Sjogrens, Perimenopausal, and Allergies to tree nuts. The patient is not pregnant. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram and estradiol (ESTROGEN). On 10Jan2021 06:00, 6 days after injection, the patient had rash broke out all over her neck which has not fully resolved after treatment with oral prednisone 20 mg for 10 days. The outcome of the event was not recovered. The patient has not been tested for COVID post vaccination.

Other Meds: ESCITALOPRAM; ESTROGEN

Current Illness:

ID: 1000530
Sex: F
Age:
State: OH

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I felt as if I head a fever; sweats; needed to vomit; felt pretty dizzy; This is a spontaneous report from a contactable consumer. A 20-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 20Jan2021 18:45 at SINGLE DOSE at left arm for COVID-19 immunization. Medical history included ulcerative colitis. The patient was not pregnant at the time of vaccination. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. After my vaccine, on 20Jan2021 19:00, the patient felt as if I "head" a fever and sweats and needed to vomit I also felt pretty dizzy, I know this was in the side effects but just wanted to make sure I was going to be okay to receive my second dose. The patient did not receive treatment for the events. The patient recovered from the events on Jan2021. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000531
Sex: F
Age:
State: CT

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:over 102.5

Allergies:

Symptoms: painful axillary lymphadenopathy; fever over 102.5; piercing headache; chills; dizziness; vertigo with movement; severe fatigue; sore throat; I felt so unwell; muscle aches; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EL9261, via an unspecified route of administration on Left arm from 19Jan2021 14:45 to 19Jan2021 14:45 as SINGLE DOSE (dose 2) for COVID-19 immunisation. Medical history included alpha thalassemia, chronic anemia, lactose intolerant, ADD. Historical vaccine includes first dose of BNT162B2 (lot number: EK9231), on 28Dec2020 at 01:15 PM, Left arm and experienced chills, piercing headache, fatigue, and vertigo. Concomitant medication included colecalciferol (VITAMIN D), and escitalopram oxalate (LEXAPRO). On 20Jan2021 2:00 AM, the patient experienced painful axillary lymphadenopathy, fever over 102.5, piercing headache, chills, dizziness and vertigo with movement, severe fatigue, sore throat, muscle aches. It took hours just for the patient to get out of bed in the morning, the patient felt so unwell. This all took place on the day after she got her second vaccine. The outcome of the events was recovering. Therapeutic measure has been given in response to the event which includes Tylenol 1000mg. The patient is not pregnant at the time of vaccination.

Other Meds: VITAMIN D [COLECALCIFEROL]; LEXAPRO

Current Illness:

ID: 1000532
Sex: F
Age:
State: CA

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bad cough; Trouble breathing; Tingling around mouth; Numbness in jaw and neck; Shaking; Red face and chest; Slight itching; This is a spontaneous report from a contactable healthcare professional (the patient). A 38-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL8982), intramuscular in the left arm on 18Jan2021 at 10:30 (at the age of 38-years-old) as a single dose for Covid-19 immunization. Medical history was not reported. The patient was allergic to penicillin. The patient previously received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EJ1685) on 28Dec2020 in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ALERTEC), both for unknown indication from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jan2021 at 11:00, the patient experienced bad cough, trouble breathing, tingling around mouth, numbness in jaw and neck, shaking, red face and chest, and slight itching. Treatment was given when seen by paramedics with an emergency room visit which included a second dose of allergy medication. The clinical outcome of the events bad cough, trouble breathing, tingling around mouth, numbness in jaw and neck, shaking, red face and chest, and slight itching was recovering. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: The reported events were likely causally related to the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), considering the plausible temporal relationship and clinical course of the events. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LEVOTHYROXINE; ALERTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1000533
Sex: F
Age:
State: FL

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling of left lymph node under left armpit; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 19Jan2021 12:45 at a single dose for COVID-19 immunization. Medical history was none. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), colecalciferol (VITAMIN D), and ethinylestradiol, norgestimate (SPRINTEC). Historical vaccine included first dose of PFIZER BIONTECH COVID 19 VACCINE on 29Dec2020 12:30 PM in the left arm for COVID-19 immunization when the patient was 32 years old. The patient was not pregnant. The patient had not received any other vaccine prior to covid vaccine. The patient experienced swelling of left lymph node under left armpit on 20Jan2021 22:15 with outcome of not recovered. Therapeutic measure was taken as a result of swelling of left lymph node under left armpit (lymphadenopathy) with OTC ADVIL.The patient had no covid prior vaccination nor was he tested post vaccination. Information on Lot/Batch number has been requested.

Other Meds: ADDERALL; VITAMIN D; SPRINTEC

Current Illness:

ID: 1000534
Sex: M
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/17/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain is very severe, includes all over the scrotum; includes all over the scrotum, with redness , induration , and kissing of the first layer of the skin; includes all over the scrotum, with redness , induration , and kissing of the first layer of the skin; kissing of the first layer of the skin all over the scrotum; inflammation of the scrotum; Got worse every day; This is a spontaneous report from a contactable physician. A 66-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284), via an unspecified route of administration on the Right arm on 07Jan2021 at a [SINGLE DOSE] for COVID-19 immunisation. Medical history included hyperlipidaemia from an unknown date and unknown if ongoing. There were no concomitant medications. The patient had the first dose on 19Dec2020. On 17Jan2021, the patient noticed inflammation of the scrotum which got worse every day. On 20Jan2021, the pain was very severe which included all over the scrotum, with redness and induration and kissing of the first layer of the skin. Therapeutic measures (Eli on ointment, triple antibiotic ointment Kenalog) were taken as a result of the events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1000535
Sex: F
Age:
State: AR

Vax Date: 01/09/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: felt a tinge of pain in my sacral area/It got worse each hour/ It worsen daily/It became painful; Became limited in movements such trying to picking up items from the floor; difficulty running or walking fast as I usually do; Lots of spasms in the sacral area; Difficulty sleeping; Difficulty sleeping and going from sitting to standing; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249, expiry date: unknown), via an unspecified route of administration in the left arm, on 09Jan2021 15:30, at single dose, for COVID-19 immunization, at the pharmacy. There was no medical history and no known allergies. Concomitant medication included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN), diphenhydramine hydrochloride (BENADRYL), herbal nos, minerals nos, nutrients nos, vitamins nos (CATALYST) and "Muscle Strength". The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient did not have other vaccines in four weeks. The patient reported that on 12Jan2021 at 14:00, "I ardently felt a tinge of pain in my sacral area. Then it got worse each hour. Then I became limited in movements such trying to picking up items from the floor and difficulty running or walking fast as I usually do. It worsened daily. I would workout and then I experienced lots of spasms in the sacral area. It became painful. The patient experienced difficulty sleeping and going from sitting to standing." The events resulted to "Doctor or other healthcare professional office/clinic visit". Treatment for the events included prescription muscle relaxants (unspecified), ibuprofen and "topi". The patient was recovering from the events.

Other Meds: EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]; BENADRYL; CATALYST

Current Illness:

ID: 1000536
Sex: F
Age:
State: IL

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Blurred vision; fatigue; dizziness; tachycardia; arm soreness; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EJ 1685), via an unspecified route of administration in the left arm on 20Dec2020 08:00 at a single dose for covid-19 immunization. Medical history included prediabetes, spinal stenosis of right back, allergies in penicillin, sulfa and yellow jacket venom. Concomitant medication included gabapentin, metformin, paracetamol (TYLENOL), diclofenac (DICLOFENAC), zinc and vitamins. On 20Dec2020 20:00, 12 hours after vaccine administration, the patient experienced blurred vision, fatigue, dizziness, tachycardia and arm soreness. The patient did not receive treatment for the events. The patient had not tested positive for COVID post vaccination. The outcome of the events was recovered on unspecified date.

Other Meds: GABAPENTIN; METFORMIN; TYLENOL; DICLOFENAC; ZINC

Current Illness:

ID: 1000537
Sex: F
Age:
State: MI

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administration date=13Jan2021, dose number=2/ administration date=21Dec2020, dose number=1; Starting 36 hr after 2nd dose had 4 days of whole body systemic hives, itching; Starting 36 hr after 2nd dose had 4 days of whole body systemic hives, itching; This is a spontaneous report from a contactable nurse. A 48-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration on the Right arm on 13Jan2021 07:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, hypothyroidism from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). The patient had the first dose of BNT162B2 on 21Dec2020. On 15Jan2021 03:00 PM, starting 36 hours after 2nd dose, the patient had 4 days of whole body systemic hives and itching. There were no respiratory symptoms. Therapeutic measures (Pepcid, Zantac, Benadryl oral and cream) were taken as a result of hives and itching. The outcome of the events was recovered on an unspecified date.

Other Meds: SYNTHROID

Current Illness:

ID: 1000538
Sex: M
Age:
State: ME

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Slight muscle discomfort; This is a spontaneous report from a contactable consumer (patient). An 82-year-old male patient received BNT162B2 (Lot number: EL3247), via an unspecified route of administration from 20Jan2021 11:15 to 20Jan2021 11:15 at single dose in the left arm for COVID-19 immunization. Medical history included blood pressure (BP) abnormal and high density lipoprotein abnormal (HDL). The patient has no known allergies. Concomitant medication included rosuvastatin calcium (CRESTOR), acetylsalicylic acid (ASP), losartan, ubidecarenone (COQ 10), ascorbic acid, tocopheryl acetate, xantofyl, zeaxanthin, zinc (AREDS) and isosorbide mononitrate (FLO). The patient experienced slight muscle discomfort on an unspecified date with outcome of unknown. The patient did not receive any treatment for the event. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds: CRESTOR; ASP; LOSARTAN; COQ 10; AREDS; FLO

Current Illness:

ID: 1000539
Sex: M
Age:
State: NJ

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Moderate pain and swelling in the injection site; Moderate pain and swelling in the injection site; moderate headache; chills; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EK4176), via an unspecified route of administration on 20Jan2021 at 14:00 at single dose on left arm for COVID-19 immunisation. Medical history and concomitant medications were none. No COVID prior vaccination. No COVID tested post vaccination. Known allergies: None. The patient experienced moderate pain and swelling in the injection site started abought 5 hours after receiving the vaccine and experienced moderate headache and chills as well, on 20Jan2021 at 21:00. No treatment was received for the events. Outcome of the events was resolving.

Other Meds:

Current Illness:

ID: 1000540
Sex: M
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Left arm soreness progressively increasing now 18 hours after injection difficulty raising arm; Left arm soreness progressively increasing now 18 hours after injection difficulty raising arm; Night sweats last night, soaked sheets/pillow/mattress; This is a spontaneous report from a non-contactable pharmacist who reported for self. A 39-year-old male patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9261), via an unspecified route of administration on 20Jan2021 14:30 at single dose on left arm for COVID-19 immunisation. Medical history was none. No COVID prior vaccination. No COVID tested post vaccination. No known allergies. Concomitant medications included ascorbic acid (VIT C) at 1 g once daily, ubidecarenone (COQ10 [UBIDECARENONE]) at 100 mg once daily, valaciclovir hydrochloride (VALTREX) at 500 mg once daily, all from unknown date for unknown indication. On 20Jan2021 at 16:30, patient experienced left arm soreness progressively increasing 18 hours after injection difficulty raising arm and night sweats last night, soaked sheets/pillow/mattress. No treatment was received. Outcome of the events was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: VIT C; COQ10 [UBIDECARENONE]; VALTREX

Current Illness:

ID: 1000541
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: Body Temp; Result Unstructured Data: Test Result:101; Comments: Fever 101; Test Date: 20210114; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: fever 101; headache; chills; muscle pain; weakness; nausea; fatigue; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on an unspecified date at 10:00 at single dose on left arm for COVID-19 immunisation. Medical history included depression/anxiety, back pain, COVID prior vaccination and known allergies: sulfa and penicillin. Concomitant medication included naproxen, sertraline HCL (ZOLOFT), fish oil, ospemifene (OSPHENA) and docusate sodium (COLACE), all from unknown date for unknown indication. On 12Jan2021 at 17:00, patient experienced fever 101, headache, chills, muscle pain, weakness, nausea and fatigue. Events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received. Nasal Swab on 14Jan2021 was negative. Patient recovered in Jan2021. Information on the lot/batch number has been requested.

Other Meds: NAPROXEN; Zoloft; FISH OIL; OSPHENA; COLACE

Current Illness:

ID: 1000542
Sex: M
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Triggered mild asthma attack; wheezing; Continued pain at injection site; Triggered a fibromyalgia episode; body pains; headache; fatigue; dizziness; This is a spontaneous report from a contactable consumer (patient himself). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247, expiry date not reported), via an unspecified route of administration in the left arm on 19Jan2021 08:45 at single dose for COVID-19 immunisation. Medical history included fibromyalgia and asthma. On 19Jan2021 16:00, the patient experienced triggered mild asthma attack, wheezing, continued pain at injection site, triggered a fibromyalgia episode, body pains, headache, fatigue, and dizziness. No therapeutic measure was taken as a result of the events. Clinical outcome of injection site pain was not recovered while for the other events was recovered on Jan2021.

Other Meds:

Current Illness:

ID: 1000543
Sex: M
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: tested positive for Covid; Test Result: Positive

Allergies:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable consumer(patient). A male patient of an unspecified age first dose received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunization . The patient medical history and concomitant medications were not reported. The patient experienced tested positive for COVID on 12Jan2021 with outcome of unknown. Patient was scheduled for second dose on 27Jan2021, while doctors can't agree on whether he should et that second dose or not. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000544
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic to the first dose; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter was asking if there was any desensitization protocol for a second dose for someone allergic to the first dose. The outcome of the event was unknown. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 1000545
Sex: F
Age:
State: NY

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Pain at location of vaccine injection when pressing and lifting arm; This is a spontaneous report from a contactable Other Health Professional reported for herself. A 23-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3247), via an unspecified route of administration on 19Jan2021 at 14:00 at single dose on left arm for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 since the vaccination. Patient was not pregnant at the time of vaccination. The patient experienced pain at location of vaccine injection when pressing and lifting arm on 19Jan2021 15:00 with outcome of recovering. Fatigue and trouble getting out of bed the morning after the shot on 20Jan2021 with outcome of recovering. This case was reported as non-serious.

Other Meds:

Current Illness:

ID: 1000546
Sex: M
Age:
State: TN

Vax Date: 01/08/2021
Onset Date: 01/11/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Continued total body myalgias; weakness; This is a spontaneous report from a contactable Other Health Professional, the patient. A 43-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the left arm on 08Jan2021 at 13:00 PM (at the age of 43-year-old) as a single dose for COVID-19 immunization. Medical history included gastrooesophageal reflux disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had sars-cov-2 test on 04Jan2021 which was negative. Concomitant medication taken within two weeks of vaccination included dexlansoprazole (DEXILANT). The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EJ1685), left arm on 19Dec2020 for COVID-19 immunization. The patient reported that he continued total body myalgias and weakness 11 days post injection. The events began on 11Jan2021. The events was reported as non serious. The patient did not receive treatment for the events. The clinical outcome of the events continued total body myalgias, and weakness was not recovered. It was also reported that since the vaccination, the patient had been tested for COVID-19.

Other Meds: DEXILANT

Current Illness:

ID: 1000547
Sex: F
Age:
State: NC

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle aches; joint pain; chills; nausea; This is a spontaneous report from a contactable consumer reporting for self. A 29-years-old female patient received Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# EK9231, via an unspecified route of administration on 28Dec2020 12:15 (at age 29 years old), as a single dose in left arm; and Dose 2, Lot# EL3247, via an unspecified route of administration on 20Jan2021 10:15 (at age 29 years old) as a single dose, left arm for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included generalised anxiety disorder, obsessive-compulsive disorder, asthma, and food allergy (citrus, berries, tropical fruits, ascorbic acid, dill, crab, tree nuts, peanuts). The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO), alprazolam (XANAX), diphenhydramine hydrochloride (BENADRYL), and ibuprofen. The patient did not receive any other vaccines in the 4 weeks prior to COVID vaccination. On unspecified dates after both first and second doses, she had muscle aches, joint pain, chills, and nausea. There was no hospitalization or treatment received for the events. The events were reported as non-serious. The patient was recovering from muscle aches, joint pain, chills, and nausea. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: LEXAPRO; XANAX; BENADRYL; IBUPROFEN

Current Illness:

ID: 1000548
Sex: U
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: covid-19 test; Result Unstructured Data: Test Result:no antibodies

Allergies:

Symptoms: I received the first vaccine and donated blood 17 days later but I showed no antibodies.; This is a spontaneous report from a contactable consumer received from Pfizer sponsored program. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration from an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first vaccine and donated blood 17 days later but showed no antibodies. The patient was interested in knowing if blood should show antibodies 17 days after 1st vaccine. The outcome of the event was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1000549
Sex: F
Age:
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: SARS-COV-2 COVID-19 (Coronavirus); Test Result: Negative ; Comments: SR008138-Salivary

Allergies:

Symptoms: headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 10:15 AM at single dose in left arm for COVID-19 immunisation. The most recent COVID-19 vaccine was administered at workplace clinic. Patient age at vaccination is 65 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 29Dec2020 06:15 PM, at single dose in right arm. Medical history included high blood pressure and high cholesterol. The patient has no allergies to medications, food, or other products/known allergies. The patient received unspecified concomitant medications. On 20Jan2021 on 01:00 PM the patient experienced a headache after second dose, it started about 24 hours after the 2nd dose. Still have it on day 2, but is not severe. Using generic Tylenol to treat it. The event was reported as non serious. The event was resolving. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 SR008138-Salivary, SARS-COV-2 COVID-19 test on 14Jan2021 with negative result.

Other Meds:

Current Illness:

ID: 1000550
Sex: F
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fatigue; slight headache; nausea; sore arm (left); swollen lymph nodes -left arm; This is a spontaneous report from a contactable consumer. A 28-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration at arm left on 20Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration at arm left on 30Dec2020 at single dose for COVID-19 immunization. On 20Jan2021, the patient experienced fatigue, slight headache, nausea, sore arm (left) and swollen lymph nodes (left arm). The patient outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1000551
Sex: F
Age:
State: KS

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Body aches; Diarrhea; This is a spontaneous report from a contactable nurse. A 55-year-old female patient received bnt162b2 (brand: Pfizer), lot/batch no. and expiration date not provided, intramuscular on 20Jan2021 at a single dose for COVID-19 immunization. Medical history included diagnosed with COVID-19 prior to vaccination. Concomitant medications included unspecified vaccine/s. The patient received other vaccines within 4 weeks prior to the COVID vaccine. The COVID-19 vaccine was administered at a nursing home/senior living facility. The patient was not pregnant at the time of vaccination. The patient experienced headache, body aches, diarrhea on 20Jan2021. No treatment received for the adverse events. All events were assessed as non-serious (did not result to death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, and no congenital anomaly/birth defect). Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000552
Sex: M
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:No fever

Allergies:

Symptoms: heavy tired; This is a spontaneous report from a contactable consumer (patient). An 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021, at 10:30 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. After vaccine the patient had no fever but feels really tired, 'heavy tired'. Has taken two aspirins for symptoms. The outcome of the event was unknown. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000553
Sex: F
Age:
State: AL

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; Chills; Headache; Cough; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on left arm on 19Jan2021 14:15 at single dose for covid-19 immunisation. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metoprolol, lisinopril, estradiol, sertraline and tramadol hydrochloride (TRA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced nausea, chills, headache, cough, all on 19Jan2021. The events were assessed as non-serious. Since the vaccination, the patient has not been tested for COVID-19. No treatment was given for the events. The outcome of the events was recovering.

Other Meds: METOPROLOL; LISINOPRIL; ESTRADIOL; SERTRALINE; TRA

Current Illness:

ID: 1000554
Sex: F
Age:
State: CA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizziness; severe injection site pain and swelling; severe injection site pain and swelling; swollen neck glands; scattered itching; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the right arm on 12Jan2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included end-stage renal failure and bipolar and the patient had known allergies to penicillin, sulfa, fish, shellfish, broccoli, and cauliflower. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medication included apixaban (ELIQUIS) from an unknown date at an unknown dose for an unknown indication. It was unknown whether the patient received any other vaccine within 4 weeks prior to the vaccine. On 12Jan2021 at 01:15 (as reported) the patient experienced severe injection site pain and swelling, swollen neck glands, scattered itching, and dizziness. The patient was treated for the arm pain with paracetamol (TYLENOL). The clinical outcome of the severe injection site pain and swelling, swollen neck glands, scattered itching, dizziness was recovered on an unknown date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.

Other Meds: ELIQUIS

Current Illness:

ID: 1000555
Sex: M
Age:
State:

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Moderate soreness at injection site lasting 24 hours; Moderate fatigue; This is a spontaneous report from a non-contactable consumer (patient) A 35-years-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) Lot# EH9899 on 19Jan2021 18:00 at SINGLE DOSE for Covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. No Covid prior vaccination. Facility where the most recent COVID-19 vaccine was hospital. The patient experienced moderate soreness at injection site lasting 24 hours on Jan2021, moderate fatigue (12-24 hrs post injection) on Jan2021. The patient had not been tested for COVID post vaccination . Outcome of the events was unknown. No follow-up attempts are possible.No further infromation expected.

Other Meds:

Current Illness:

ID: 1000556
Sex: F
Age:
State: PA

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210120; Test Name: Fever; Result Unstructured Data: Test Result:103.6 Fahrenheit

Allergies:

Symptoms: Fever 103.6F with chills; Fever 103.6F with chills; Vomiting; This is a spontaneous report from a contactable other healthcare professional reporting for a patient. A 71-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EH9899, via an unspecified route of administration on 19Jan2021 at 11:15 (at the age of 71 years old) as a single dose in the right arm for COVID-19 vaccination. Medical history included hypertension, seizures, hypothyroid, and attention deficit disorder all from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication names were not reported, but it was reported that she used other medications in two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination, The vaccine was given at a Nursing Home/Senior Living Facility. On 20Jan2021 at 12:00AM, the patient experienced fever 103.6F with chills, and vomiting. The patient received treatment of Tylenol 1gm once only for fever and chills. The clinical outcome of fever 103.6F with chills, and vomiting was recovered on an unspecified date in Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1000557
Sex: F
Age:
State: TN

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: believes it has a little fever; Got the first shot, there was a little soreness; Redness at the injection site for about 4-5 days; The rash is back/ Injection site rash is getting bigger; little itchy/ Itchy with a lump in it; Itchy with a lump in it; Little swollen at the injections site; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3246) intramuscular on the left arm from 07Jan2021 at a single dose for COVID-19 vaccination. The patient had no medical history. There were no concomitant medications. The patient reported that she got the first shot and noticed redness at the injection site for about 4-5 days in Jan2021 and then it went away. Reported that 2-3 days ago she noticed that the rash was back or the redness at the injection site was back and itchy with a lump in it. She reported that the spot was 2 inches in diameter then went to 3 inches, so it was enlarged. She was asking "should I put something on it?" and "the next shot is on the 28th, should I get it?". She got the first shot on 07Jan2021, there was a little soreness. It took it from then until Monday for the redness to go away at the injection site and it did go away but then last night she was putting on lotion and she looked on the arm there it was back again there was a 2 inch red circle and it looks like it has little rash type thing in it and it was itchy. She had a redness and it looked little swollen at the injections site (Jan2021). She noticed the injection site rash was getting bigger, referring to the little rash around the site, and it was a little itchy and she believed it has a little fever. Added it was 2 inches and now it was 3 inches. Outcome of the events vaccination site pain and vaccination site warmth was unknown, while not recovered for the other events.

Other Meds:

Current Illness:

ID: 1000558
Sex: U
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe diarrhea; Vomiting; This is a spontaneous report from a contactable consumer (patient). This 78-year-old patient of unspecified gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 15Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the higher dose flu vaccine on an unspecified date for an unspecified indication and they got sick. The patient developed severe diarrhea and some vomiting on an unspecified date in Jan2021. The patient reported they still had diarrhea; further reporting that they read that the second dose caused more problem and consequently the reporter was considering not taking that dose. The patient reported they were sensitive to vaccine so they can only take the lower dose flu vaccine. The patient reported the one time they had the higher dose flu vaccine they got sick. The reporter's son wanted the reporter to take the second dose of the COVID vaccine but the patient fears they may land in the hospital if they do. The clinical outcome of the event was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1000559
Sex: U
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable Physician. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for an unspecified indication. The patient medical history and concomitant medications were not reported. The patient tested positive for covid-19 infection on 11Jan2021 with outcome of unknown. The reported wanted to know how long the patient should wait before receiving the second dose. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 1000560
Sex: M
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: Body Temp; Result Unstructured Data: Test Result:low grade fever

Allergies:

Symptoms: Stiffness in left arm; Body chills; low grade fever; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at arm left on 20Jan2021 at 09:30 at single dose for COVID-19 immunization. The patient medical history was none. The patient's concomitant medications were not reported. On 21Jan2021 at 03:00, the patient experienced stiffness in left arm, body chills and low-grade fever. The patient outcome of the events was not recovered. The information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 1000561
Sex: U
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no side effects except a sore arm and I feel great; This is a spontaneous report from a contactable consumer. This 68-years-old elderly consumer (patient) of unknown gender received first and second doses of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown), via an unspecified route of administration on unknown date at single dose for an COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated she experienced "no side effects except a sore arm and I feel great" on unknown date. The outcome of event "no side effects except a sore arm and I feel great" was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1000562
Sex: F
Age:
State: AZ

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: COVID saliva test; Result Unstructured Data: Test Result:Positive; Comments: More information available (Y/N): No

Allergies:

Symptoms: She got tested with the COVID saliva test on 09Jan2021 and tested positive; She got tested with the COVID saliva test on 09Jan2021 and tested positive; headache; not feeling well; fell super run down; This is a spontaneous report from a contactable consumer. A 47-years-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899) via an unspecified route of administration at single dose arm left on 06Jan2021 16:45 for covid-19 immunisation. Medical history included allergy induced asthma, neoplasm malignant since 2011 (reported as 10 years ago), ongoing white blood cell count decreased. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) for allergy induced asthma, cetirizine hydrochloride (ZYRTEC) for allergy. No other vaccine was received in four weeks. Patient had headache on 09Jan2021, not feeling well on 09Jan2021, fell super run down on 09Jan2021. The patient got tested with the covid saliva test on 09Jan2021 and was positive. Patient just wanted to know if she can go forward to 2nd dose. The outcome of headache was not recovered, of fell super run down was recovering, of the other events was unknown.

Other Meds: SYMBICORT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness: White blood cell count low

ID: 1000563
Sex: M
Age:
State: OK

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I am very tired; have been sleeping both day and night since I had my Covid-19 injection; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL1293), via an unspecified route of administration, in the left arm on 19Jan2021 at 18:00 PM (at the age of 78-year-old) as a single dose for COVID-19 immunization. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included oxycodone, gabapentin, morniflumate (FLOMAX), acetylsalicylic acid (ASPIRIN ), and metaxalone. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has known allergies to morphine. On 20Jan2021 at 05:00 AM, the patient experienced being tired. The patient reported "I am very tired, I have been sleeping both day and night since I had my Covid-19 injection". The patient did not receive treatment for the events. The clinical outcome of the events tired and I have been sleeping both day and night since I had my Covid-19 injection was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: OXYCODONE; GABAPENTIN; FLOMAX; ASPIRIN; METAXALONE

Current Illness:

ID: 1000564
Sex: F
Age:
State: NC

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itching and burning sensation around the face, ears and arms and continued down the back, legs to the feet; itching and burning sensation around the face, ears and arms and continued down the back, legs to the feet; This is a spontaneous report from a contactable health professional, the patient. A 72-year-old non-pregnant female patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EL3246), via an unspecified route of administration in the left arm on 20Jan2021 at 11:45 (at the age of 72-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were none. The patient had no known allergies. The patient was not diagnosed with COVID prior to the vaccination. The patient did not receive any other vaccines within 4 weeks of the vaccination. On 20Jan2021 at 23:30 (the evening after receiving the first dose), the patient experienced an itching and burning sensation around the face, ears and arms and continued down the back, legs to the feet. The patient was treated for the events with 1 tablet of expired diphenhydramine (BENADRYL), one to one and a half hours after which the symptoms started to improve and by 02:00 the patient was able to get some sleep. Since the vaccination, the patient was not tested for COVID. The clinical outcome of "itching and burning sensation around the face, ears and arms and continued down the back, legs to the feet" was resolved on 21Jan2021.

Other Meds:

Current Illness:

ID: 1000565
Sex: M
Age:
State:

Vax Date: 12/28/2020
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a non-contactable Consumer (patient). A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested positive to covid-19 in Jan2021 (last week) with outcome of unknown. The patient wanted to know when he should receive the second dose. No follow-up attempts are possible. Information on Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000566
Sex: F
Age:
State: HI

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Minimal soreness at site; This is a spontaneous report from a contactable consumer (patient). This 81-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3248), via an unknown route of administration, on 20Jan2021 at 10:30 at a single dose on the left arrm for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After vaccination, the patient had minimal soreness at site. Second shot was scheduled on 04Mar2021. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1000567
Sex: F
Age:
State: PA

Vax Date: 01/05/2021
Onset Date: 01/07/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lymph node swelling; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ek9231, expiry date unknown), intramuscular at the right arm on 05Jan2021, 15:00 at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications included atenolol and ibuprofen (MOTRIN). The patient previously received first dose of BNT162B2 for COVID-19 immunization on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19 and not tested for COVID-19 since vaccination. Patient was not pregnant at the time of vaccination. The patient experienced lymph node swelling on 07Jan2021. The event resulted to physician office visit (Doctor or other healthcare professional office/clinic visit). No treatment was received for the event. The outcome of the event was recovered on Jan2021. The event was non-serious.

Other Meds: ATENOLOL; MOTRIN

Current Illness:

ID: 1000568
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling of tongue; swelling of the throat; This is a spontaneous report from a non-contactable consumer received via a Pfizer sales representative. An adult patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) via an unspecified route of administration on unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within four weeks prior to the covid vaccine. It was unknown if the patient was diagnosed with covid 19 prior to vaccine. It was unknown if the patient tested for covid 19 since the vaccination. On unspecified date, the patient experienced swelling of tongue and swelling of the throat. The events were assessed as non-serious. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000569
Sex: M
Age:
State: MD

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling on his face; hives all over his body; dose 1 administration date: 22Dec2020, dose 2 administration date: 14Jan2021; This is a spontaneous report from a non-contactable consumer via a Pfizer sales representative. An adult male patient received a second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot and expiry date: not reported), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Allergies to medications, food, or other products was unknown. The patient previously received the first dose of BNT162B2 on 22Dec2020 for COVID-19 immunization. On 18Jan2021, it was reported that the patient experienced swelling on his face and hives all over his body. The patient also received the first dose on 22Dec2020 and the second dose on 14Jan2021. Treatment received was reported as unknown. The outcome of the events swelling on his face and hives all over his body was recovering. The reporter assessed the event as non-serious. The events did not result in death, life threatening condition, prolonged hospitalization, disability or congenital anomaly or birth defect. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination and if the patient was tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000570
Sex: F
Age:
State: AZ

Vax Date: 01/16/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Extreme fatigue 5 days later I am still having extreme fatigue; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot and expiry were not available), via an unspecified route of administration in the right arm on 16Jan2021 at 10:30 at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included asthma and high cholesterol. No allergies to medications, food, or other products. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT), atorvastatin calcium (ARVASTATIN) and azelastine which were received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme fatigue 5 days later (on 21Jan2021 at 12:00). The patient stated, "I am still having extreme fatigue." The event was considered non-serious as it did not result in death, non-life threatening, did not cause/prolong hospitalization, non- disabling/incapacitating and no congenital anomaly/birth defect. The outcome of the event was recovering. No treatment was received for the adverse event. Information on the lot/batch number has been requested.

Other Meds: SYMBICORT; ARVASTATIN; AZELASTINE

Current Illness:

ID: 1000571
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: red and swollen arm; red and swollen arm; This is a spontaneous report from a contactable consumer. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration single dose on 12Jan2021 for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced red and swollen arm on 20Jan2021. The outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm